Clinical Trial Search

Primary: Medication Adherence — 88.1; 96.6; 94.4 percentage of doses taken (pill count)

Primary: Medication Adherence — 94.8; 82.8 percentage of doses taken

Primary: Percent of Participants With Adherence at Month 6 — 91; 40 percent persistent on therapy — p=<0.05

Primary: Blood Pressure Medication Adherence — 396; 470 Participants — p=0.0103

Primary: Medication Specific Knowledge — 63.82; 62.80 score (0-100)

Primary: Rate of Medication Adherence — 0.76; 0.79; 0.83 percentage of doses taken — p=0.78

Primary: Number of Participants Assessed for Intraocular Pressure Change — 0; 4; 4; 8 Participants

Primary: Antipsychotic Medication Adherence — 63.9; 75.0 percentage of participants — p=0.03

Primary: Change in Medication Adherence as Measured by the Adherence to Refills and Medications Scale (ARMS) — -4.0; -1.0 score on a scale

Primary: Primary Effectiveness Outcome - LDL — 57.9; 54.8 percentage of time spent at goal

Primary: Medication Adherence - Pill Count — 0.46; 0.53 Probability of adherence (PT/PP => 0.8) — p=0.04

Primary: Systolic Blood Pressure — 134.5; 141.7; 134.6 mm Hg

Primary: Proportion of Days Covered With Medicine — 0.69 Proportion of days covered with medicine

Primary: Medication Possession Ratio at Baseline — 65.0 percentage of medication possession

Primary: Compliance of Flupentixol-Melitracen — 44; 28; 31 participants

Primary: Raw Count of Number of Days of Medication Nonadherence — 28 % of nonadherence days

Primary: System Performance - Positive Detection Accuracy — 80 percentage of ingestions

Primary: Drug Use Problems — 1.25; 0.86; 1.20; 1.17 scores on a scale

Primary: Intervention Feasibility as Measured by Number of Providers Agreeing to Participate — 6 Participants

Primary: Adherence to Medication — 2; 3 Participants

Primary: Feasibility of AMDD to Improve Medication Adherence Via Completion Rate — 15 participants

Primary: Percentage of Participants Who Were Compliant With Statin Treatment — 86.7 Percentage of participants

Primary: Change in Treatment Adherence Within the Past Month as Measured by the Tablet Routines Questionnaire — -27.8 units on a scale — p=<.001

Primary: Medication Adherence at 1 Month — 11.83; 10.20; 9.33 score on a scale

Primary: Percentage of Visits With Appropriate Hypertension Management — 34; 69 percentage of patient-clinician visits — p=<=0.001

Primary: Percentage of Participants With Positive Response on Increased Motivation Using a Self-test at Month 12 — 36.2 Percentage of participants

Primary: Median Proportion of Days Covered (PDC) at 8-months Post-enrollment — 0.94; 0.88 proportion of days covered (PDC) — p=0.001

Primary: Proportion of Days Covered With Medicine — 0.24; 0 proportion of days covered with medicine — p=0.08

Primary: Adherence to Refills and Medications Scale (ARMS) — 12.03; 12.18 units on a scale

Primary: Statin Adherence — 86; 85; 86; 85 percentage of correct statin doses